245 related articles for article (PubMed ID: 19250962)
1. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
[TBL] [Abstract][Full Text] [Related]
2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
Hof PR; Cox K; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease.
Duong T; Gallagher KA
Mol Chem Neuropathol; 1994 Jun; 22(2):105-22. PubMed ID: 7916770
[TBL] [Abstract][Full Text] [Related]
5. Modular and laminar pathology of Brodmann's area 37 in Alzheimer's disease.
Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
Neuroscience; 2008 Mar; 152(1):50-5. PubMed ID: 18222045
[TBL] [Abstract][Full Text] [Related]
6. Posterior parahippocampal gyrus pathology in Alzheimer's disease.
Thangavel R; Van Hoesen GW; Zaheer A
Neuroscience; 2008 Jun; 154(2):667-76. PubMed ID: 18486350
[TBL] [Abstract][Full Text] [Related]
7. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
[TBL] [Abstract][Full Text] [Related]
8. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.
Vickers JC; Riederer BM; Marugg RA; Buée-Scherrer V; Buée L; Delacourte A; Morrison JH
Neuroscience; 1994 Sep; 62(1):1-13. PubMed ID: 7816192
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.
Hof PR; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
Shepherd CE; Thiel E; McCann H; Halliday GM
Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
[TBL] [Abstract][Full Text] [Related]
11. Casein kinase II alteration precedes tau accumulation in tangle formation.
Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
[TBL] [Abstract][Full Text] [Related]
12. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
[TBL] [Abstract][Full Text] [Related]
13. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease.
Brion JP; Couck AM; Conreur JL
Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
[TBL] [Abstract][Full Text] [Related]
16. Spreading of Tau Pathology in Sporadic Alzheimer's Disease Along Cortico-cortical Top-Down Connections.
Braak H; Del Tredici K
Cereb Cortex; 2018 Sep; 28(9):3372-3384. PubMed ID: 29982389
[TBL] [Abstract][Full Text] [Related]
17. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
[TBL] [Abstract][Full Text] [Related]
18. Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.
Soffer D; Umansky F; Goldman JE
Acta Neuropathol; 1995; 89(5):451-3. PubMed ID: 7542425
[TBL] [Abstract][Full Text] [Related]
19. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
20. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments.
Nishikawa T; Takahashi T; Nakamori M; Hosomi N; Maruyama H; Miyazaki Y; Izumi Y; Matsumoto M
Neuropathol Appl Neurobiol; 2016 Dec; 42(7):639-653. PubMed ID: 26501932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
